Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study.

Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR.

Lancet. 2002 Jan 12;359(9301):118-23.

PMID:
11809254
2.

The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.

Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL.

J Am Coll Cardiol. 2004 Mar 17;43(6):985-90.

3.

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.

García Rodríguez LA, Varas-Lorenzo C, Maguire A, González-Pérez A.

Circulation. 2004 Jun 22;109(24):3000-6. Epub 2004 Jun 14.

4.

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63. doi: 10.1002/pds.1820.

PMID:
19637402
5.

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.

Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):155-63. doi: 10.1161/CIRCOUTCOMES.108.805689. Epub 2009 May 5.

6.
7.
8.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FW, Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Gimona A, Matchaba P, Hawkey CJ, Chesebro JH; TARGET Study Group.

Lancet. 2004 Aug 21-27;364(9435):675-84.

PMID:
15325832
9.

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR.

Lancet. 2002 Oct 5;360(9339):1071-3.

PMID:
12383990
10.

Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?

van Staa TP, Rietbrock S, Setakis E, Leufkens HG.

J Intern Med. 2008 Nov;264(5):481-92. doi: 10.1111/j.1365-2796.2008.01991.x. Epub 2008 Jun 25.

11.

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.

Solomon DH, Glynn RJ, Levin R, Avorn J.

Arch Intern Med. 2002 May 27;162(10):1099-104.

PMID:
12020178
13.

Association between naproxen use and protection against acute myocardial infarction.

Rahme E, Pilote L, LeLorier J.

Arch Intern Med. 2002 May 27;162(10):1111-5. Erratum in: Arch Intern Med 2002 Sep 9;162(16):1858.

PMID:
12020180
14.

Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.

Hochain P, Berkelmans I, Czernichow P, Duhamel C, Tranvouez JL, Lerebours E, Colin R.

Eur J Gastroenterol Hepatol. 1995 May;7(5):419-26.

PMID:
7614104
15.

Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.

Velentgas P, West W, Cannuscio CC, Watson DJ, Walker AM.

Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):641-52.

PMID:
16392153
16.
18.

[Are the NSAIDs able to compromising the cardio-preventive efficacy of aspirin?].

Flipo RM.

Presse Med. 2006 Sep;35(9 Spec No 1):1S53-60. Review. French.

PMID:
17078596
19.

Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction.

Dalen JE.

Arch Intern Med. 2002 May 27;162(10):1091-2. Review. No abstract available.

PMID:
12020175

Supplemental Content

Support Center